Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06638320 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hepatitis Delta Virus Infection: Cross-sectional Study in Patients With Chronic Hepatitis B Virus Infection

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 months later Jul 30, 2026 → Nov 30, 2026
See other at-risk trials from Tam Anh Research Institute

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jul 30, 2026 to Nov 30, 2026
    • Secondary endpoints: details revised at 2 of 2 entries
    • Eligibility criteria expanded, about 3 words
  2. Re-verified, no change to tracked fieldsv4
  3. Trial status: Active, Not Recruiting to Recruiting
    • Primary completion date: Mar 10, 2025 to Jul 30, 2026
    • Study sites: 1 to 3
    • Study completion date: Dec 30, 2025 to Dec 30, 2026
    v3
  4. Trial status: Not Yet Recruiting to Active, Not Recruitingv2 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date changed from estimate of Jun 30, 2025 to Mar 10, 2025
    • Study completion date: Jun 30, 2025 to Dec 30, 2025
    • Start date changed from estimate of Oct 1, 2024 to Nov 1, 2024
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this observational study is to determine the prevalence of hepatitis D virus (HDV) and the distribution of the HDV genotype in patients with chronic hepatitis B infection. It will also identify factors related to hepatitis D virus infection, such as characteristics of the study sample, vaccination history, drug use affecting hepatitis, family factors, environment, and lifestyle. This study will be conducted at Tam Anh General Hospital, Bach Mai Hospital and Tam Anh TP. Ho Chi Minh General Hospital. Participants will be interviewed directly through a questionnaire to collect some information related to epidemiological risk factors. A blood sample will also be collected.
Trial Details
NCT Number NCT06638320
Lead Sponsor Tam Anh Research Institute
Conditions
(from sponsor)		 Hepatitis Delta With Hepatitis B Carrier State, Chronic Hepatitis b
Related terms Hepatitis B, Chronic
Enrollment 2,452 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov